Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven D Pearson

Showing results (81-90 of 169) with videos related to

Pageof 17
Sort By:
Journal of Managed Care & Specialty Pharmacy|March 26, 2021
The effectiveness and value of digital health technologies as an adjunct to medication-assisted therapy for opioid use disorderJeffrey A Tice, Melanie D Whittington, Jonathan D Campbell, et al.
Journal of Comparative Effectiveness Research|November 15, 2018
A framework to guide the optimal development and use of real-world evidence for drug coverage and formulary decisionsSteven D Pearson, William B Dreitlein, Adrian Towse, et al.
Journal of Comparative Effectiveness Research|November 10, 2018
Real-world evidence for coverage decisions: opportunities and challengesGrace Hampson, Adrian Towse, William B Dreitlein, et al.
Journal of Managed Care & Specialty Pharmacy|October 1, 2021
The effectiveness and value of belimumab and voclosporin for lupus nephritisJeffrey A Tice, Olena Mandrik, Praveen Thokala, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 13, 2021
Does Cost-Effectiveness Analysis Overvalue Potential Cures? Exploring Alternative Methods for Applying a "Shared Savings" Approach to Cost OffsetsRichard H Chapman, Varun M Kumar, Melanie D Whittington, et al.
Journal of Comparative Effectiveness Research|November 19, 2013
Management options for children with attention-deficit/hyperactivity disorder: a regional perspective on valueDaniel A Ollendorf, Kristen Migliaccio-Walle, Jennifer A Colby, et al.
Journal of Comparative Effectiveness Research|March 1, 2021
Cornerstones of 'fair' drug coverage: appropriate cost sharing and utilization management policies for pharmaceuticalsSteven D Pearson, Adrian Towse, Maria Lowe, et al.
Health Services Research|February 12, 2009
Roundtable on expanding capacity for comparative effectiveness research in the United States: discussion took place on June 3, 2007, at the AcademyHealth Annual Research Meetingin Orlando, FLSean Tunis, Carolyn Clancy, W David Helms, et al.
Journal of Managed Care & Specialty Pharmacy|June 29, 2021
The effectiveness and value of bempedoic acid and inclisiran for heterozygous familial hypercholesterolemia and secondary prevention of ASCVDFoluso Agboola, Grace A Lin, Dhruv S Kazi, et al.
Archives of Pediatrics & Adolescent Medicine|June 1, 2002
Effects of removing gatekeeping on specialist utilization by children in a health maintenance organizationTimothy G Ferris, Yuchiao Chang, James M Perrin, et al.
Pageof 17

Showing results (81-90 of 169) with videos related to

Sort By:
Pageof 17
Journal of Managed Care & Specialty Pharmacy|March 26, 2021
The effectiveness and value of digital health technologies as an adjunct to medication-assisted therapy for opioid use disorderJeffrey A Tice, Melanie D Whittington, Jonathan D Campbell, et al.
Journal of Comparative Effectiveness Research|November 15, 2018
A framework to guide the optimal development and use of real-world evidence for drug coverage and formulary decisionsSteven D Pearson, William B Dreitlein, Adrian Towse, et al.
Journal of Comparative Effectiveness Research|November 10, 2018
Real-world evidence for coverage decisions: opportunities and challengesGrace Hampson, Adrian Towse, William B Dreitlein, et al.
Journal of Managed Care & Specialty Pharmacy|October 1, 2021
The effectiveness and value of belimumab and voclosporin for lupus nephritisJeffrey A Tice, Olena Mandrik, Praveen Thokala, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 13, 2021
Does Cost-Effectiveness Analysis Overvalue Potential Cures? Exploring Alternative Methods for Applying a "Shared Savings" Approach to Cost OffsetsRichard H Chapman, Varun M Kumar, Melanie D Whittington, et al.
Journal of Comparative Effectiveness Research|November 19, 2013
Management options for children with attention-deficit/hyperactivity disorder: a regional perspective on valueDaniel A Ollendorf, Kristen Migliaccio-Walle, Jennifer A Colby, et al.
Journal of Comparative Effectiveness Research|March 1, 2021
Cornerstones of 'fair' drug coverage: appropriate cost sharing and utilization management policies for pharmaceuticalsSteven D Pearson, Adrian Towse, Maria Lowe, et al.
Health Services Research|February 12, 2009
Roundtable on expanding capacity for comparative effectiveness research in the United States: discussion took place on June 3, 2007, at the AcademyHealth Annual Research Meetingin Orlando, FLSean Tunis, Carolyn Clancy, W David Helms, et al.
Journal of Managed Care & Specialty Pharmacy|June 29, 2021
The effectiveness and value of bempedoic acid and inclisiran for heterozygous familial hypercholesterolemia and secondary prevention of ASCVDFoluso Agboola, Grace A Lin, Dhruv S Kazi, et al.
Archives of Pediatrics & Adolescent Medicine|June 1, 2002
Effects of removing gatekeeping on specialist utilization by children in a health maintenance organizationTimothy G Ferris, Yuchiao Chang, James M Perrin, et al.
Pageof 17